93 related articles for article (PubMed ID: 13434140)
1. [Comparative results of therapy in parenchymal liver diseases].
GEISBERGER H
Wien Med Wochenschr; 1957 Mar; 107(12):240-2. PubMed ID: 13434140
[No Abstract] [Full Text] [Related]
2. [Treatment of obesity].
Netto LF
Resen Clin Cient; 1969; 38(7):195-9. PubMed ID: 5398776
[No Abstract] [Full Text] [Related]
3. [Critical evaluation of cholinemethionine therapy in liver diseases].
KIPPING H
Dtsch Med J; 1954 Dec; 5(23-24):669-72. PubMed ID: 14352896
[No Abstract] [Full Text] [Related]
4. [Therapy with hepsan in practice].
DOLAINSKI O
Ther Ggw; 1953 Dec; 92(12):444-6. PubMed ID: 13136093
[No Abstract] [Full Text] [Related]
5. [Modern indications for liver-protective therapy].
Boll Soc Med Chir Cremona; 1954; 8(3-5):65-8. PubMed ID: 13230287
[No Abstract] [Full Text] [Related]
6. [Clinical treatment of acute and chronic liver diseases].
Szabb L
Z Allgemeinmed; 1972 Feb; 48(4):182-4. PubMed ID: 5015143
[No Abstract] [Full Text] [Related]
7. LIPOTROPICS as invaluable therapeutic agents.
J Iowa State Med Soc; 1952 Feb; 42(2):66-7. PubMed ID: 14908214
[No Abstract] [Full Text] [Related]
8. [The fate of the liver in alcoholics. II. Use of lipotropic factors in the treatment of hepatic dysfunction].
NADEAU G; ROULEAU Y; DELAGE J
Laval Med; 1954 Jan; 19(1):52-8. PubMed ID: 13153180
[No Abstract] [Full Text] [Related]
9. [Methionine and choline in diseases of liver parenchyma].
HOBURG H
Dtsch Med J; 1955 Sep; 6(17-18):586-7. PubMed ID: 13261815
[No Abstract] [Full Text] [Related]
10. [Drug therapy of hepatitis in childhood].
Ortlieb R
Monatsschr Kinderheilkd (1902); 1975 Aug; 123(8):626-7. PubMed ID: 51472
[No Abstract] [Full Text] [Related]
11. [A new hepatic therapeutic preparation. Its use in pediatrics].
Chiossi FM
Minerva Pediatr; 1971 Oct; 23(41):1714-20. PubMed ID: 5316225
[No Abstract] [Full Text] [Related]
12. [Therapy of the fatty liver with lipotropic substances].
JANSEN L
Med Klin; 1956 Jan; 51(2):54-6. PubMed ID: 13296790
[No Abstract] [Full Text] [Related]
13. [Protective action of vitamins and amino acids against the cytotoxic effect of phosphamide and Acrex].
Zolotnikova GP; Dorofeev VM
Farmakol Toksikol; 1978; 41(2):186-8. PubMed ID: 658362
[TBL] [Abstract][Full Text] [Related]
14. LIPOTROPIC supplements in fatty cirrhosis.
Treat Serv Bull; 1953 Jan; 8(1):41-3. PubMed ID: 13029158
[No Abstract] [Full Text] [Related]
15. [How to conduct therapeutic research. Therapeutic agents for liver diseases].
Enomoto H
Nihon Rinsho; 1966 Aug; 24(8):1463-9. PubMed ID: 6008864
[No Abstract] [Full Text] [Related]
16. [New data in hepato-biliary therapeutics; lipotropic substances and synthetic cholagogues].
GAUDIN MO
Deltion Iatrocheirourgike Hetaireia Athenon; 1953; 2():171-6. PubMed ID: 13127427
[No Abstract] [Full Text] [Related]
17. The use of lipotropic factors in the treatment of liver disease.
CAYER D; CORNATZER WE
Gastroenterology; 1952 Mar; 20(3):385-402. PubMed ID: 14906636
[No Abstract] [Full Text] [Related]
18. [Treatment of experimental liver necrobiosis].
Wagner KH; Wagner-Hering E
Nahrung; 1971; 15(2):141-60. PubMed ID: 5172906
[No Abstract] [Full Text] [Related]
19. [Therapeutic results with Hepsan in selected forms of hepatitis].
Schneider-Reinkens A
MMW Munch Med Wochenschr; 1977 Jun; 119(25):869-70. PubMed ID: 408608
[No Abstract] [Full Text] [Related]
20. [Considerations on the therapy of hepatic steatosis].
Pisi E; Bianchi FB; Nigro F
Minerva Med; 1969 Aug; 60(69):3117-32. PubMed ID: 5824710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
